bos-innovation-square (3)

CHICAGO—Life sciences companies large and small continue to pay top dollar for amenities-rich locations and facilities in a select group of top US markets, according to JLL's latest Life Sciences Outlook. Year after year, the metro areas of Boston, San Francisco, San Diego and Raleigh-Durham have proven most attractive to this research-heavy industry. But that does not mean no changes will occur in the sector over the next few years.

“Like any industry, life sciences are trying to attract and retain talent,” Roger Humphrey, executive managing director and leader of Chicago-based JLL's life sciences group, tells GlobeSt.com. “And that means serving a multi-generational workforce.”

Of course, he adds, creating collaborative spaces that millennials find attractive is hardly unique to life sciences. But shifting parts of this industry, which has been heavily concentrated in suburban office parks, to the more urban spaces desired by younger workers presents several challenges.

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Brian J. Rogal

Brian J. Rogal is a Chicago-based freelance writer with years of experience as an investigative reporter and editor, most notably at The Chicago Reporter, where he concentrated on housing issues. He also has written extensively on alternative energy and the payments card industry for national trade publications.

brianjrogal

Just another ALM site